STERIS plc (NYSE:STE) Shares Acquired by Dana Investment Advisors Inc.

Dana Investment Advisors Inc. grew its holdings in STERIS plc (NYSE:STE) by 84.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,174 shares of the medical equipment provider’s stock after acquiring an additional 1,452 shares during the quarter. Dana Investment Advisors Inc.’s holdings in STERIS were worth $652,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in STE. Ashton Thomas Securities LLC acquired a new stake in STERIS in the third quarter worth about $25,000. Human Investing LLC acquired a new stake in STERIS in the fourth quarter worth about $31,000. Anfield Capital Management LLC boosted its holdings in STERIS by 100.0% in the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 91 shares in the last quarter. Central Pacific Bank Trust Division boosted its holdings in STERIS by 65.5% in the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC boosted its holdings in STERIS by 182.7% in the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after acquiring an additional 137 shares in the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Trading Up 0.3 %

Shares of NYSE:STE opened at $233.02 on Friday. The business has a 50-day moving average price of $216.96 and a 200-day moving average price of $222.78. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. The stock has a market cap of $22.89 billion, a price-to-earnings ratio of 49.47 and a beta of 0.92. STERIS plc has a 52-week low of $197.82 and a 52-week high of $248.24.

STERIS (NYSE:STE) last announced its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Equities analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, March 21st. Investors of record on Thursday, February 20th will be given a dividend of $0.57 per share. This represents a $2.28 annualized dividend and a yield of 0.98%. The ex-dividend date is Thursday, February 20th. STERIS’s dividend payout ratio is currently 48.41%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on STE shares. Piper Sandler raised their price objective on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Stephens restated an “overweight” rating and issued a $240.00 price objective on shares of STERIS in a research note on Thursday, February 6th. Finally, JMP Securities restated a “market outperform” rating and issued a $265.00 price objective on shares of STERIS in a research note on Thursday, February 6th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $258.75.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.